Medicine and Dentistry
Randomized Controlled Trial
99%
Intensive Care Unit
93%
Randomized Clinical Trial
93%
Staphylococcus aureus
93%
Critical Illness
70%
Methicillin Susceptible Staphylococcus Aureus
60%
Quality of Life
59%
Artificial Respiration
56%
Delirium
53%
Cost-Effectiveness Analysis
46%
Intensive Care
46%
Diagnostic Test Accuracy Study
46%
Faintness
46%
Brain Ischemia
46%
Electrocardiography Monitoring
46%
Cardiac Fibrosis
46%
Aortic Stenosis
46%
Early Intervention
46%
Macrophage
46%
Liver Injury
46%
Paracetamol
46%
Eradication Therapy
46%
Cilostazol
46%
Isosorbide Mononitrate
46%
Orthopedic Surgery
46%
Joint Replacement
26%
Meticillin
26%
Hazard Ratio
23%
Conservative Treatment
23%
Intervention Trial
23%
Rivermead Mobility Index
23%
Infection Complication
23%
Cardiac Dysrhythmia
19%
Propofol
19%
Health Care Cost
19%
Orthopedics
19%
Aortic Valve
15%
Acute Liver Failure
15%
Clonidine
13%
Prevalence
13%
Sedative Agent
13%
Dexmedetomidine
13%
Analgesia
13%
Healthcare Associated Infection
13%
Emergency Department
12%
Coma
12%
Small Vessel Disease
11%
Lacunar Stroke
11%
Joint Stiffness
9%
Neck Disability Index
9%
Nursing and Health Professions
Delirium
100%
Intensive Care Unit
77%
Critical Illness
62%
Ward
57%
Diagnostic Test Accuracy Study
51%
Cost Effectiveness Analysis
51%
Artificial Respiration
48%
Randomization
46%
Sedation
46%
Diagnostic Accuracy
46%
Intensive Care
46%
Quality of Life
37%
Confidence Interval
28%
Health Economics
26%
Infection Complication
23%
Economic Evaluation
22%
Health Care Personnel
20%
Propofol
19%
Length of Stay
15%
Rivermead Mobility Index
15%
Hospital Discharge
15%
Analgesia
13%
Clonidine
13%
Sedative Agent
13%
Dexmedetomidine
13%
Coma
12%
Practice Guideline
11%
Diseases
10%
Receiver Operating Characteristic
10%
Joint Stiffness
9%
Brain Injury
6%
Heart Arrest
6%
Richmond Agitation Sedation Scale
6%
Extubation
6%
Adverse Event
6%
Posttraumatic Stress Disorder
6%
DSM-IV
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
93%
Staphylococcus Aureus
46%
Aortic Stenosis
46%
Cilostazol
46%
Delirium
46%
Liver Injury
46%
Randomized Clinical Trial
46%
Isosorbide Mononitrate
46%
Paracetamol
46%
Methicillin Susceptible Staphylococcus Aureus
46%
Heart Muscle Fibrosis
46%
Tissue Factor Pathway Inhibitor
46%
Cerebrovascular Disease
46%
Lacunar Stroke
37%
Acute Liver Failure
31%
Infection Complication
23%
Liver Necrosis
15%
Toxic Injury
15%
Clinical Trial
15%
Diseases
14%
Prevalence
13%
Bleeding
9%
Cardioembolic Stroke
9%
Cerebrovascular Accident
9%
Phase III Trials
9%
Recurrent Disease
9%
Cognitive Defect
9%
Pathophysiology
9%
Population Study
6%
Surgical Infection
6%
Healthcare Associated Infection
6%